ZINZINO AB (PUBL): INTERIM REPORT SECOND QUARTER 2024

STRONG GROWTH AND PROFITABILITY DURING AN EVENTFUL QUARTER

Revenues in the second quarter of 2024 amounted to SEK 507.0 (407.9) million, corresponding to 24% (24%) growth compared to the corresponding period last year. EBITDA increased to SEK 63.0 (53.7) million, and the EBITDA margin amounted to 12.4% (13.2%). During the quarter, Zinzino acquired the rights to Luxembourg-based Xelliss SA distributor database, inventory and IP assets, acquired 49% of the shares in the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD and signed a letter of intent to acquire the US direct sales company Zurvita INC. In addition, the launch of Serbia was announced as the next step in the global expansion.

APRIL-JUNE

• Total revenue amounted to SEK 507.0 (407.9) million, corresponding to a growth of 24% (24%)
• Gross profit amounted to SEK 174.5 (148.5) million and the gross profit margin amounted to 34.4% (36.4%)
• EBITDA profit amounted to SEK 63.0 (53.7) million and the EBITDA margin amounted to 12.4% (13.2%)
• Cash flow from operating activities amounted to SEK 91.1 (46.3) million

JANUARY-JUNE

• Total revenue amounted to SEK 961.6 (801.6) million, corresponding to a growth of 20% (21%)
• Gross profit amounted to SEK 335.4 (279.2) million, and the gross profit margin amounted to 34.9% (34.8%)
• EBITDA profit amounted to SEK 114.7 (98.1) million, and the EBITDA margin amounted to 11.9% (12.2%)
• Cash flow from operating activities amounted to SEK 94.2 (111.3) million
• Cash and cash equivalents amounted to SEK 296.0 (200.9) million on the balance sheet date

Link to the report:
https://www.zinzino.com/site/GB/en-GB/about/investor-relations/

For more information, please contact:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, email: dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 707 900 174, email: fredrik.nielsen@zinzino.com

Images for free publication:
marketing@zinzino.com

Certified Adviser: Carnegie Investment Bank AB (publ.)

This information is information that Zinzino AB (publ) is obliged to make public according to the EU's market abuse regulation. The information was provided by the above contact person for publication at 08:00 the 30th of August,2024.

Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino owns the Swiss, biotech skincare brand HANZZ+HEIDII, as well as the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The company headquarters is in Gothenburg, Sweden with additional offices in Europe, Asia, the US and Australia.